Wellgistics Health Files 8-K
Ticker: WGRX · Form: 8-K · Filed: Sep 8, 2025 · CIK: 2030763
Sentiment: neutral
Topics: disclosure, regulatory-filing
TL;DR
Wellgistics Health filed an 8-K, mostly standard disclosures, no major news yet.
AI Summary
Wellgistics Health, Inc. (formerly Danam Health, Inc.) filed an 8-K on September 8, 2025, reporting events as of September 5, 2025. The filing primarily concerns Regulation FD Disclosure and includes Financial Statements and Exhibits. No specific financial transactions or material events were detailed in the provided excerpt.
Why It Matters
This 8-K filing indicates a regulatory disclosure by Wellgistics Health, Inc., providing transparency to investors about company events and financial statements.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosures and exhibits, with no immediate indication of significant negative events.
Key Players & Entities
- Wellgistics Health, Inc. (company) — Registrant
- Danam Health, Inc. (company) — Former name of registrant
- September 5, 2025 (date) — Earliest event date
- September 8, 2025 (date) — Filing date
- 3000 Bayport Drive Suite 950 (address) — Principal executive office address
- Tampa, FL 33607 (address) — Principal executive office city, state, zip
FAQ
What is the primary purpose of this 8-K filing for Wellgistics Health, Inc.?
The primary purpose is for Regulation FD Disclosure and to file Financial Statements and Exhibits, as indicated by the filing's item information.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on September 5, 2025.
What was Wellgistics Health, Inc. formerly known as?
Wellgistics Health, Inc. was formerly known as Danam Health, Inc.
What is the principal executive office address for Wellgistics Health, Inc.?
The principal executive office address is 3000 Bayport Drive Suite 950, Tampa, FL 33607.
What is the SIC code for Wellgistics Health, Inc.?
The Standard Industrial Classification (SIC) code for Wellgistics Health, Inc. is 5122, which corresponds to WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES.
Filing Stats: 1,093 words · 4 min read · ~4 pages · Grade level 11.3 · Accepted 2025-09-08 08:15:48
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex99-1.htm (EX-99.1) — 12KB
- ex99-2.htm (EX-99.2) — 21KB
- ex99-3.htm (EX-99.3) — 2KB
- ex99-2_001.jpg (GRAPHIC) — 271KB
- ex99-2_002.jpg (GRAPHIC) — 257KB
- ex99-2_003.jpg (GRAPHIC) — 287KB
- ex99-2_004.jpg (GRAPHIC) — 256KB
- ex99-2_005.jpg (GRAPHIC) — 259KB
- ex99-2_006.jpg (GRAPHIC) — 326KB
- ex99-2_007.jpg (GRAPHIC) — 219KB
- ex99-2_008.jpg (GRAPHIC) — 274KB
- ex99-2_009.jpg (GRAPHIC) — 239KB
- ex99-2_010.jpg (GRAPHIC) — 267KB
- ex99-2_011.jpg (GRAPHIC) — 315KB
- ex99-2_012.jpg (GRAPHIC) — 239KB
- ex99-2_013.jpg (GRAPHIC) — 249KB
- ex99-2_014.jpg (GRAPHIC) — 242KB
- ex99-2_015.jpg (GRAPHIC) — 269KB
- ex99-2_016.jpg (GRAPHIC) — 246KB
- ex99-2_017.jpg (GRAPHIC) — 274KB
- ex99-2_018.jpg (GRAPHIC) — 274KB
- ex99-2_019.jpg (GRAPHIC) — 253KB
- ex99-2_020.jpg (GRAPHIC) — 77KB
- ex99-2_021.jpg (GRAPHIC) — 373KB
- ex99-2_022.jpg (GRAPHIC) — 371KB
- ex99-2_023.jpg (GRAPHIC) — 70KB
- ex99-2_024.jpg (GRAPHIC) — 319KB
- ex99-2_025.jpg (GRAPHIC) — 268KB
- ex99-2_026.jpg (GRAPHIC) — 255KB
- ex99-2_027.jpg (GRAPHIC) — 357KB
- ex99-2_028.jpg (GRAPHIC) — 264KB
- ex99-2_029.jpg (GRAPHIC) — 234KB
- ex99-2_030.jpg (GRAPHIC) — 258KB
- ex99-3_001.jpg (GRAPHIC) — 577KB
- ex99-3_002.jpg (GRAPHIC) — 590KB
- 0001641172-25-026812.txt ( ) — 12689KB
- wgrx-20250905.xsd (EX-101.SCH) — 3KB
- wgrx-20250905_lab.xml (EX-101.LAB) — 33KB
- wgrx-20250905_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Wellgistics Health, Inc. Dated: September 8, 2025 By: /s/ Mark DiSiena Mark DiSiena Chief Financial Officer